To assess whether selinexor could overcome this effect, we incubated CLL cells with IL-4 + CD40L 1 h prior to incubation with selinexor for a further 24 h and then assessed HLA-E. This evidence concerns the gene IL4 and B-cell chronic lymphocytic leukemia.